The Parsortix cell separation system successfully developed by ANGLE plc has moved into the regulatory authorisation and market launch phase. The system captures intact circulating tumor cells from cancer patient blood and has been positively evaluated by research partners. ANGLE is now focused on securing the necessary regulatory approvals to commercialize the Parsortix system and address the multi-billion dollar clinical cancer treatment market.
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
ANGLE Peliminary Results 2013 31jul13
1. Parsortix PR1 System successfully developed
Moving into regulatory authorisation and
market launch phase
Andrew Newland and Ian Griffiths
31 July 2013